Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics
Authors:
- Mohammad AlkhatibMAMohammad Alkhatib
- John N. HansonJHJohn N. Hanson
- Ashley N. NilsonANAshley N. Nilson
- Amy E. MoritzAMAmy E. Moritz
- Tian LiTLTian Li
- Afua B. FaibilleAFAfua B. Faibille
- Lindsay A. BournLBLindsay A. Bourn
- Peter A. RamdhanPRPeter A. Ramdhan
- Joseph Ricchezza IvJIJoseph Ricchezza Iv
- Shannon JordanSJShannon Jordan
Preprint
- 15 September 2025
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Dopamine D4 receptor (D4R) signaling affects decision-making, memory formation, cognition, and attention. Previously developed D4R-selective ligands were metabolically unstable in vivo due to amide bond linker hydrolysis. In this study, analog compounds were synthesized using click chemistry, bioisosterically replacing amides with a 1,2,3-triazole linker. Herein, we report 1,2,3-triazole analogs maintained high D4R affinity and subtype selectivity while retaining their functional activity. Using rat and human liver microsomes to evaluate phase I metabolism, we determined that amide ligands were more metabolically unstable in rat microsomes, and the triazole substitutions enhanced compound stability. Four compounds were evaluated in rat pharmacokinetics studies. In particular, 17 (antagonist) and 18 (low-efficacy partial agonist) had desirable results in plasma half-life and brain exposure measures. These new analogs are suitable for behavioral studies in rats and represent improved molecular tools to further explore D4R signaling in rodent models.Keywords
All Related Versions
Funding Information
- National Institutes of Health (R21DA050896, DP1DA058385, T34GM136492, ZIA-NS002263)
This publication has 39 references indexed in Scilit:
- Discovery and characterization of benzyloxy piperidine based dopamine 4 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2022
- Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseasesEuropean Journal of Medicinal Chemistry, 2021
- Lessons learned from comparing molecular dynamics engines on the SAMPL5 datasetJournal of Computer-Aided Molecular Design, 2016
- Putative therapeutic targets for symptom subtypes of adult ADHD: D4 receptor agonism and COMT inhibition improve attention and response inhibition in a novel translational animal modelEuropean Neuropsychopharmacology, 2015
- Dopamine D4 Receptors in Psychostimulant Addiction2014
- Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: Implications for neuropsychiatric disordersBehavioural Brain Research, 2010
- The dopamine D4 receptor: biochemical and signalling propertiesCellular and Molecular Life Sciences, 2010
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Isosterism and bioisosterism in drug design1991